B of A Securities Maintains Buy on Chevron, Raises Price Target to $227...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Why Is Salesforce Stock Surging Tuesday?...
Apple, Microsoft, Meta, Amazon Earnings: Why The Next 48 Hours Could Redefine The AI Trade...
Shares of data center infrastructure-related companies are trading lower as growth-oriented, AI-exposed stocks continue their retracement amid concern...
QUICK SPARK: Jim Cramer Says Boeing Stock Is 'Ready to Run'...
China Developments Spark KOSPI Crash, US Semi Stocks Follow As Fed Decision Looms...
Microsoft Could Swing $189 Billion in Value After Earnings...
Amazon, Apple, Meta, Microsoft Earnings on Deck: 33% of Benzinga Viewers Say This is Top Report to Watch...
'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seni...
Visa Q3 Adj. EPS $3.32 Beats $3.23 Estimate, Sales $11.633B Beat $11.388B Estimate...
Visa Reports $563M As Severance Expenses...
Visa Posts Strong Q3 Results: CEO Says 'Consumer and Business Spending Remains Resilient'...
CLARITY Act Vote Delayed as Senate Turns to Russia Sanctions: What Do Prediction Markets Forecast?...
B of A Securities Maintains Buy on Intel, Maintains $160 Price Target...
'OpenAI's rogue agent compromised an account at a second tech firm, executive says'- Reuters Exclusive...
QUICK SPARK: Goldman's High Beta Momentum Basket Heads for Worst Month Ever...
HIKMA Pharmaceuticals announced on Tuesday that the U.S. FDA approved its Abbreviated New Drug Application (ANDA 218728), signaling a positive pipelin...
Somerset Therapeutics has received FDA approval for the intravenous formulation of sugammadex, the antidote to rocuronium bromide, marking a pivotal e...
Hikma Pharmaceuticals USA Inc. announced on Friday the approval of sugammaDEX sodium for the intravenous treatment of hyperkalemia, securing a key FDA...
TEVA PHARMS USA INC announced the FDA approval of its ANDA application 214126, clearing the way for the launch of the generic version of the Blockbust...